Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Achieve Life Sciences, Inc. (ACHV)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Visitors trend2W10W9M
4.7100+0.0100 (+0.21%)
At close: 04:00PM EDT
4.6200 -0.09 (-1.91%)
After hours: 04:56PM EDT
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 3/24/2023
Current
Market Cap (intraday)
N/A
Enterprise Value
N/A
Trailing P/E
N/A
Forward P/E
N/A
PEG Ratio (5 yr expected)
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue
N/A
Enterprise Value/EBITDA
N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 1.48
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 38.1300
52 Week Low 32.0000
50-Day Moving Average 34.8468
200-Day Moving Average 34.1322

Share Statistics

Avg Vol (3 month) 3104.78k
Avg Vol (10 day) 3108.27k
Shares Outstanding 517.9M
Implied Shares Outstanding 6N/A
Float 89.63M
% Held by Insiders 18.29%
% Held by Institutions 135.54%
Shares Short (Jan 30, 2023) 4599.7k
Short Ratio (Jan 30, 2023) 44.61
Short % of Float (Jan 30, 2023) 43.35%
Short % of Shares Outstanding (Jan 30, 2023) 43.35%
Shares Short (prior month Dec 29, 2022) 4852.92k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Jul 30, 2020
Ex-Dividend Date 4N/A
Last Split Factor 21:20
Last Split Date 3Jul 30, 2020

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Sep 29, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-75.28%
Return on Equity (ttm)-214.13%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -36.82M
Net Income Avi to Common (ttm)-38.27M
Diluted EPS (ttm)-5.4180
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)18.2M
Total Cash Per Share (mrq)1.87
Total Debt (mrq)15.79M
Total Debt/Equity (mrq)1,512.07
Current Ratio (mrq)3.03
Book Value Per Share (mrq)6.10

Cash Flow Statement

Operating Cash Flow (ttm)-31.62M
Levered Free Cash Flow (ttm)-18.17M
Advertisement
Advertisement